Completed PHASE2 NCT00045981

The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SAPPHIRE Study

Sponsor: Synvista Therapeutics, Inc

Interventions ALT-711

Updated 5 times since 2017 Last updated: Mar 25, 2010 Started: Oct 31, 2001 Primary completion: May 31, 2003 Completion: Aug 31, 2006

This PHASE2 trial investigates Hypertension and is currently completed. Synvista Therapeutics, Inc leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Synvista Therapeutics, Inc

Data source: Synvista Therapeutics, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.